Sarika Pharmaceuticals has spent billions of dollars on the research and development of a new drug. It wants to patent the drug and have market power. Naturally, it will price it above the socially efficient level to:
a) Maximize profit
b) Promote public health
c) Encourage competition
d) Reduce consumer costs